Sridharan Rajagopal
- Co-authors
- Murugesan VelayudhamZong‐Zhan LuPitchaimani VeerakumarKuang‐Lieh LuMichael NovákRamachandraiah GosuS. ChandrasekaranNarayanan Surendran
- Topics
- Histone Deacetylase Inhibitors Research (13 papers)Protein Degradation and Inhibitors (6 papers)Synthesis and Biological Evaluation (5 papers)
- Partner nations
- IndiaUnited StatesGermany
In The Last Decade
Sridharan Rajagopal
39 papers receiving 651 citations
Peers
Comparison fields: 5 of 103
- Molecular Biology 239
- Organic Chemistry 196
- Immunology 88
- Oncology 79
- Materials Chemistry 72
Countries citing papers authored by Sridharan Rajagopal
This map shows the geographic impact of Sridharan Rajagopal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sridharan Rajagopal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sridharan Rajagopal more than expected).
Fields of papers citing papers by Sridharan Rajagopal
This network shows the impact of papers produced by Sridharan Rajagopal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sridharan Rajagopal. The network helps show where Sridharan Rajagopal may publish in the future.
Co-authorship network of co-authors of Sridharan Rajagopal
This figure shows the co-authorship network connecting the top 25 collaborators of Sridharan Rajagopal. A scholar is included among the top collaborators of Sridharan Rajagopal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sridharan Rajagopal. Sridharan Rajagopal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 43 | |
| 3 | 13 | |
| 4 | 7 | |
| 5 | 59 | |
| 6 | 2 | |
| 7 | 29 | |
| 8 | 2 | |
| 9 | 1 | |
| 10 | 2 | |
| 11 | 13 | |
| 12 | 9 | |
| 13 | 8 | |
| 14 | 7 | |
| 15 | 39 | |
| 16 | 40 | |
| 17 | 2 | |
| 18 | 9 | |
| 19 | Inhibition of human colon cancer malignant cell behavior and growth by antisense epidermal growth factor receptor expression vector. | 6 |
| 20 | 37 |
About Sridharan Rajagopal
Sridharan Rajagopal is a scholar working on Geriatrics and Gerontology, Applied Microbiology and Biotechnology and Physical and Theoretical Chemistry, having authored 42 papers that have together received 667 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (13 papers), Protein Degradation and Inhibitors (6 papers) and Synthesis and Biological Evaluation (5 papers). The work is most often cited by research in Organic Chemistry (196 citations), Immunology (88 citations) and Geriatrics and Gerontology (16 citations). Sridharan Rajagopal has collaborated with scholars based in India, United States and Germany. Frequent co-authors include Murugesan Velayudham, Zong‐Zhan Lu, Pitchaimani Veerakumar, Kuang‐Lieh Lu, Michael Novák, Ramachandraiah Gosu, S. Chandrasekaran, Narayanan Surendran, Shridhar Narayanan and Mendel Tuchman. Their work appears in journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.